High Dose Carfilzomib for Newly Diagnosed Myeloma

Clinical trial NCT02937571 · COMPLETED

Trial details

NCT number: NCT02937571
Sponsor: Memorial Sloan Kettering Cancer Center
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Multiple Myeloma

Start date: 2016-10-01
Primary completion: 2024-10-08
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.